Absence of COVID-19 Infection in Patients Accessing IBD Unit at Humanitas, Milan: Implications for Postlockdown Measures.

Szczegóły
Abstrakt

Tytuł:: Absence of COVID-19 Infection in Patients Accessing IBD Unit at Humanitas, Milan: Implications for Postlockdown Measures.
Autorzy:: Fiorino G; IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
Gilardi D; IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy.
Radice S; IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy.
Furfaro F; IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy.
Allocca M; IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
Danese S; IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
Źródło:: The American journal of gastroenterology [Am J Gastroenterol] 2020 Oct; Vol. 115 (10), pp. 1719-1721.
Typ publikacji:: Journal Article
Język:: English
Imprint Name(s):: Publication: <2019-> : [Philadelphia, PA] : Wolters Kluwer Health
Original Publication: New York, Elsevier Science, -2003.
MeSH Terms:: Coronavirus Infections/*prevention & control
Hospital Units/*statistics & numerical data
Immunosuppressive Agents/*adverse effects
Infection Control/*statistics & numerical data
Inflammatory Bowel Diseases/*immunology
Pandemics/*prevention & control
Pneumonia, Viral/*prevention & control
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Betacoronavirus/immunology ; COVID-19 ; COVID-19 Testing ; Clinical Laboratory Techniques/statistics & numerical data ; Coronavirus Infections/diagnosis ; Coronavirus Infections/epidemiology ; Coronavirus Infections/immunology ; Follow-Up Studies ; Health Services Accessibility/statistics & numerical data ; Humans ; Infectious Disease Transmission, Patient-to-Professional/prevention & control ; Infectious Disease Transmission, Patient-to-Professional/statistics & numerical data ; Infectious Disease Transmission, Professional-to-Patient/prevention & control ; Infectious Disease Transmission, Professional-to-Patient/statistics & numerical data ; Inflammatory Bowel Diseases/drug therapy ; Italy/epidemiology ; Middle Aged ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/immunology ; Risk Factors ; SARS-CoV-2 ; Young Adult
References:: D'Amico F, Peyrin-Biroulet L, Danese S. Inflammatory bowel diseases and COVID-19: The invisible enemy. Gastroenterology 2020;158(8):2302–4.
Allocca M, Fiorino G, Furfaro F, et al. Maintaining the quality standards of care for inflammatory bowel disease patients during the COVID-19 pandemic. Clin Gastroenterol Hepatol 2020:18(8):1882–3.
International Organization for the study of Inflammatory Bowel Disease (IOIBD). IOIBD Update on COVID19 for Patients with Crohn's Disease and Ulcerative Colitis. (https://www.ioibd.org/ioibd-update-on-covid19-for-patients-with-crohns-disease-and-ulcerative-colitis/) (2020). Accessed May 5, 2020.
Fiorino G, Allocca M, Furfaro F, et al. Inflammatory bowel disease care in the COVID-19 pandemic era: The Humanitas, Milan experience. J Crohns Colitis 2020. doi:10.1093/ecco-jcc/jjaa058. (PMID: 10.1093/ecco-jcc/jjaa058)
Allocca M, Fiorino G, Furfaro F, et al. Maintaining the quality standards of care for inflammatory bowel disease patients during the COVID-19 pandemic. Clin Gastroenterol Hepatol 2020;18(8):1882–3.
The Lancet. COVID-19: Protecting health-care workers. Lancet 2020;395:922.
Wang J, Zhou M, Liu F. Reasons for healthcare workers becoming infected with novel coronavirus disease 2019 (COVID-19) in China. J Hosp Infect 2020;105(1):100–1.
European Federation of Crohn's and Colitis Associations (EFCCA). COVID-19 IBD Patients' Perception. (https://www.efcca.org/en/covid-19-ibd-patients-perception) (2020). Accessed May 5, 2020.
Brenner EJ, Ungaro RC, Gearry RB, et al. Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: Results from an international registry. Gastroenterology 2020. doi: 10.1053/j.gastro.2020.05.032. (PMID: 10.1053/j.gastro.2020.05.032)
Yang Y, Peng F, Wang R, et al. The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. J Autoimmun 2020:102434.
Substance Nomenclature:: 0 (Immunosuppressive Agents)
Entry Date(s):: Date Created: 20200828 Date Completed: 20201013 Latest Revision: 20210506
Update Code:: 20240105
PubMed Central ID:: PMC7499879
DOI:: 10.14309/ajg.0000000000000829
PMID:: 32852334
: Czasopismo naukowe

Introduction: The risk of coronavirus disease-19 infection for healthcare professionals and patients in hospitals remains unclear.
Methods: We investigated whether precautions adopted in our inflammatory bowel disease (IBD) unit have minimized the risks of infection for all patients accessing our facilities in a 1-month period by assessing the rate of coronavirus disease-19 infection in the follow-up period.
Results: Three hundred-twenty patients with IBD were included. None were infected from severe acute respiratory syndrome-coronavirus 2 in the follow-up period. None of the IBD team members were infected.
Discussion: Neither pharmacological immunosuppression nor access to the hospital seem to be risk factors for infection in patients with IBD.

Informacja